SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹0.34 Cr | ₹0.25 Cr | ₹0.46 Cr | ₹0.43 Cr | ₹0.15 Cr |
What is the latest Total Non-Current Liabilities ratio of SAMRAT PHARMACHEM ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹0.34 Cr |
Mar2023 | ₹0.25 Cr |
Mar2022 | ₹0.46 Cr |
Mar2021 | ₹0.43 Cr |
Mar2020 | ₹0.15 Cr |
How is Total Non-Current Liabilities of SAMRAT PHARMACHEM Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.34 Cr | 32.28 | |
Mar2023 | ₹0.25 Cr | -44.90 | |
Mar2022 | ₹0.46 Cr | 6.47 | |
Mar2021 | ₹0.43 Cr | 198.62 | |
Mar2020 | ₹0.15 Cr | - |
Compare Total Non-Current Liabilities of peers of SAMRAT PHARMACHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAMRAT PHARMACHEM | ₹116.5 Cr | -10.8% | -15.4% | 9.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
SAMRAT PHARMACHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAMRAT PHARMACHEM | -10.8% |
-15.4% |
9.8% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses